The article reports that advances in generative AI now allow systems to design novel proteins and DNA sequences with growing speed and accuracy, raising urgent biosecurity concerns among scientists. While these tools promise major benefits for medicine, materials science, and disease research, experts warn they could also lower barriers to creating harmful biological agents if misused. Researchers argue that existing oversight frameworks were built for an earlier era of biotechnology and are not equipped to handle AI-driven design capabilities. The piece stresses that the technology is progressing faster than governance, creating a narrow window to establish safeguards, access controls, and monitoring before risks escalate. Overall, the article frames AI-enabled biology as a powerful breakthrough that demands proactive global rules to balance innovation with safety.
